Incidence and clinical outcomes of nosocomial infections in patients presenting with STEMI complicated by cardiogenic shock in the United States.


Journal

Heart & lung : the journal of critical care
ISSN: 1527-3288
Titre abrégé: Heart Lung
Pays: United States
ID NLM: 0330057

Informations de publication

Date de publication:
Historique:
received: 06 07 2020
revised: 31 07 2020
accepted: 17 08 2020
pubmed: 1 9 2020
medline: 5 3 2021
entrez: 1 9 2020
Statut: ppublish

Résumé

This study addresses the incidence, trends, and impact of nosocomial infections (NI) on the outcomes of patients admitted with ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock (STEMI-CS) using the United States National Inpatient Sample (NIS) database. We analyzed data from 105,184 STEMI-CS patients using the NIS database from the years 2005-2014. NI was defined as infections of more than or equal to three days, comprising of central line-associated bloodstream infection (CLABSI), urinary tract infection (UTI), hospital-acquired pneumonia (HAP), Clostridium difficile infection (CDI), bacteremia, and skin related infections. Outcomes of the impact of NI on STEMI-CS included in-hospital mortality, length of hospital stay (LOS) and costs. Significant associations of NI in patients admitted with STEMI-CS were also identified. Overall, 19.1% (20,137) of patients admitted with STEMI-CS developed NI. Trends of NI have decreased from 2005-2014. The most common NI were UTI (9.2%), followed by HAP (6.8%), CLABSI (1.5%), bacteremia (1.5%), skin related infections (1.5%), and CDI (1.3%). The strongest association of developing a NI was increasing LOS (7-9 days; OR: 1.99; 95% CI: 1.75-2.26; >9 days; OR: 4.51; 95% CI: 4.04-5.04 compared to 4-6 days as reference). Increased mortality risk among patients with NI was significant, especially those with sepsis-associated NI compared to those without sepsis (OR: 2.95; 95% CI: 2.72-3.20). Patients with NI were found to be associated with significantly longer LOS and higher costs, irrespective of percutaneous mechanical circulatory support placement. NI were common among patients with STEMI-CS. Those who developed NI were at a greater risk of in-hospital mortality, increased LOS and costs.

Identifiants

pubmed: 32866743
pii: S0147-9563(20)30354-X
doi: 10.1016/j.hrtlng.2020.08.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

716-723

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no relationships relevant to the contents of this paper to disclose.

Auteurs

Omar Chehab (O)

Department of Medicine, Detroit Medical Center/Wayne State University School of Medicine, Detroit, Michigan, USA. Electronic address: omar.chehab@wayne.edu.

Rami Z Morsi (RZ)

Department of Neurology, University of Chicago, Chicago, Illinois, USA.

Amjad Kanj (A)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Rayan Jo Rachwan (RJ)

Department of Cardiovascular Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Mohit Pahuja (M)

Department of Medicine, Detroit Medical Center/Wayne State University School of Medicine, Detroit, Michigan, USA.

Shareef Mansour (S)

Division of Cardiovascular Medicine, Department of Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

Hussam Tabaja (H)

Department of Medicine, Detroit Medical Center/Wayne State University School of Medicine, Detroit, Michigan, USA.

Usman Ahmad (U)

Department of Medicine, Detroit Medical Center/Wayne State University School of Medicine, Detroit, Michigan, USA.

Said El Zein (SE)

Department of Medicine, Detroit Medical Center/Wayne State University School of Medicine, Detroit, Michigan, USA.

Mohammad Raad (M)

Division of Cardiology, Department of Medicine, Henry Ford Hospital, Detroit, Michigan, USA.

Ali Saker (A)

Department of Medicine, Detroit Medical Center/Wayne State University School of Medicine, Detroit, Michigan, USA.

Paulino Alvarez (P)

Division of Cardiovascular Medicine, Department of Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

Alexandros Briasoulis (A)

Division of Cardiovascular Medicine, Department of Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA. Electronic address: alexandros-briasoulis@uiowa.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH